08 mayo 2018

Pharma Mar : Sylentis announces new data on the treatment of allergic conjunctivitis .

05/07/2018 .

Within the framework of ARVO 2018,

Sylentis announces new data on the treatment of allergic conjunctivitis

 The results of SYL116011 have demonstrated that this treatment reduces the symptoms related to the allergy in 50% to 80%i.

 The ARVO meeting has considered the poster presentation to be of scientific interest, contributing therefore to its release.

 Around 30% of the worldwide population show allergic symptoms and between 40-80% of them have the symptoms in their eyesii.

...